Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; the references it cites are not checked yet.

Canadian clinical practice guidelines for acute and chronic rhinosinusitis

Open access
Desrosiers, Martin, Evans, Gerald A, Keith, Paul K, Wright, Erin D, Kaplan, Alan, Bouchard, Jacques, Ciavarella, Anthony, Doyle, Patrick W, Javer, Amin R, Leith, Eric S, Mukherji, Atreyi, Schellenberg, R Robert, Small, Peter, Witterick, Ian J·2011·Allergy, Asthma & Clinical Immunology

Abstract

This document provides healthcare practitioners with information regarding the management of acute rhinosinusitis (ARS) and chronic rhinosinusitis (CRS) to enable them to better meet the needs of this patient population. These guidelines describe controversies in the management of acute bacterial rhinosinusitis (ABRS) and include recommendations that take into account changes in the bacteriologic landscape. Recent guidelines in ABRS have been released by American and European groups as recently as 2007, but these are either limited in their coverage of the subject of CRS, do not follow an evidence-based strategy, or omit relevant stakeholders in guidelines development, and do not address the particulars of the Canadian healthcare environment.Advances in understanding the pathophysiology of CRS, along with the development of appropriate therapeutic strategies, have improved outcomes for patients with CRS. CRS now affects large numbers of patients globally and primary care practitioners are confronted by this disease on a daily basis. Although initially considered a chronic bacterial infection, CRS is now recognized as having multiple distinct components (eg, infection, inflammation), which have led to changes in therapeutic approaches (eg, increased use of corticosteroids). The role of bacteria in the persistence of chronic infections, and the roles of surgical and medical management are evolving. Although evidence is limited, guidance for managing patients with CRS would help practitioners less experienced in this area offer rational care. It is no longer reasonable to manage CRS as a prolonged version of ARS, but rather, specific therapeutic strategies adapted to pathogenesis must be developed and diffused.Guidelines must take into account all available evidence and incorporate these in an unbiased fashion into management recommendations based on the quality of evidence, therapeutic benefit, and risks incurred. This document is focused on readability rather than completeness, yet covers relevant information, offers summaries of areas where considerable evidence exists, and provides recommendations with an assessment of strength of the evidence base and degree of endorsement by the multidisciplinary expert group preparing the document.These guidelines have been copublished in both Allergy, Asthma & Clinical Immunology and the Journal of Otolaryngology-Head and Neck Surgery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1710-1492-7-2

Cites

Statistics

Figures

Figure 1 Algorithm for the Diagnosis and Treatment of ABRS.
Figure 1 Algorithm for the Diagnosis and Treatment of ABRS.CC BY · PubMed Central
Figure 2 Trends in Antimicrobial Resistance in Canada [58,59]
Figure 2 Trends in Antimicrobial Resistance in Canada [58,59]CC BY · PubMed Central
Figure 3 Algorithm for the Diagnosis and Management of CRS.
Figure 3 Algorithm for the Diagnosis and Management of CRS.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 252 · Cited by 313

Research works printed but not linked: 4

  1. IMS Health: Canadian Disease and Therapeutic Index (CDTI) database. 2006
  2. Green K, Pong-Porter S: Trends in antimicrobial prescribing and pneumococcal resistance, Canada, 1993-2005. 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy San Francisco. 2006
  3. Green K, McGreer A: Trends in antimicrobial resistance in Canadian strains of Streptococcus pneumoniae, 1988-2003. 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy Chicago. 2003
  4. Canadian Pharmacists Association: Compendium of pharmaceuticals and specialties. The Canadian drug reference for health professionals. 2007, Ottawa: Canadian Pharmacists Association

Metadata

Authors
Desrosiers, M., Evans, G. A., Keith, P. K., Wright, E. D., Kaplan, A., Bouchard, J., Ciavarella, A., Doyle, P. W., Javer, A. R., Leith, E. S., Mukherji, A., Schellenberg, R. R., Small, P., & Witterick, I. J.
Affiliations
  • Montreal General Hospital (CA)
  • Queen's University (CA)
  • McMaster University (CA)
  • University of Alberta (CA)
  • Brampton Civic Hospital (CA)
  • Université Laval (CA)
  • University of British Columbia (CA)
  • University of Toronto (CA)
  • Hamilton General Hospital (CA)
  • Jewish General Hospital (CA)
Corresponding author
Desrosiers, Martin
Venue
Allergy, Asthma & Clinical Immunology
Published
2011-02-10
Volume
7
Issue
1
Pages
2-2
ISSN
  • 1710-1484 (ISSN-L)
  • 1710-1492
OpenAlex
W2164959292
Cited by
313
References
252
Citations by year
2026: 7 · 2025: 14 · 2024: 10 · 2023: 17 · 2022: 13 · 2021: 18 · 2020: 20 · 2019: 20 · 2018: 29 · 2017: 28 · 2016: 28 · 2015: 35 · 2014: 27 · 2013: 28 · 2012: 15
FWCI
21.48
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/2.0 (tdm)
Locations
  • Allergy Asthma and Clinical Immunology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (publishedVersion)
  • TSpace (University of Toronto) (acceptedVersion)
  • cIRcle (University of British Columbia) (submittedVersion, cc-by)
Funders
  • GlaxoSmithKline
  • Sanofi
  • Canadian Association of Emergency Physicians
  • Association of Medical Microbiology and Infectious Disease Canada
  • Merck Canada
Topics
  • Health Sciences › Medicine › Otorhinolaryngology › Sinusitis and nasal conditions
  • Health Sciences › Medicine › Infectious Diseases › Otolaryngology and Infectious Diseases
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
Keywords
acute sinusitis, chronic rhinosinusitis, acute bacterial rhinosinusitis, corticosteroids, sinus surgery, primary care management, evidence-based recommendations

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Canadian clinical practice guidelines for acute and chronic rhinosinusitis. https://app.cochat.ai/papers/10.1186/1710-1492-7-2
The paper
Desrosiers, M., Evans, G. A., Keith, P. K., Wright, E. D., Kaplan, A., Bouchard, J., Ciavarella, A., Doyle, P. W., Javer, A. R., Leith, E. S., Mukherji, A., Schellenberg, R. R., Small, P., & Witterick, I. J. (2011). Canadian clinical practice guidelines for acute and chronic rhinosinusitis. Allergy, Asthma & Clinical Immunology. https://doi.org/10.1186/1710-1492-7-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.